Mylan, an American generic pharmaceutical company with a branch out here in New Zealand, recently recalled three types of painkiller tablets due to the risk that the tablets are more potent than the label indicates.
Ho hum
Mylan announce the recall here whilst the American drugs regulator, the FDA, announce it here.
In mid December last year Mylan New Zealand admitted to a bereaved mother that their antidepressant, Fluox, was the probable cause of her son's suicide. Safe to say then that the Fluox tablets were more potent than the label indicated.
There was no public announcement via their web page or by the New Zealand drugs regulator, Medsafe.
Just making a comparison folks.
Back stories:
Mylan's Fluox Can Probably Induce Suicide, admit Mylan
Mylan NZ, a Lawyer, Causality and U-Turn
Mylan Pharmaceuticals: The Emails, U-Turns and Denials
Mylan NZ and the 36 Hours
